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Abstract 
Mycoplasma pneumoniae is primarily a respiratory pathogen but may affect exhibit a 
diverse range of presentations from asymptomatic infection to life threatening 
conditions. Myocarditis of varying severity is an unusual complication. We report a 6 
year old with mycoplasma myocarditis, a rare age for such a presentation, and who 
responded well to treatment with no sequelae. Serological testing for Mycoplasma 
pneumoniae should be part of the routine work-up for myocarditis. 
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Introduction 
Mycoplasma is the smallest free-living organism and is unique among prokaryotes in 
that it lacks a cell wall. This feature is largely responsible for particular biologic 
properties including lack of a Gram stain reaction and nonsusceptibility to many 
commonly prescribed antimicrobial agents, including beta lactams. Mycoplasma 
pneumoniae is a common pathogen that first linked to respiratory infections in 1898 
when Roux and Nocard isolated the organisms from bovine pleuropneumonia 
specimens. Initially Mycoplasma species were thought to be viral in nature because 
of their size, and this was disproved by the presence of both mycoplasma DNA and 
RNA. Mycoplasma pneumoniae has an unusually small genome (800Kb)1 and is an 
obligatory parasite. Mycoplasma pneumoniae can be communicated through close 
personal contact via respiratory droplets and has an increased prevalence in autumn 
and winter.2 
Mycoplasma pneumoniae is predominantly a respiratory pathogen but may also 
involve other systems. The incidence of non-respiratory manifestations of 
Mycoplasma. pneumoniae varies greatly. Exanthems and gastrointestinal symptoms 
are quite common,3 whereas Mycoplasma-associated carditis (myo- or pericarditis) is 
an uncommon complication, occurring in only 1-5% of patients. We report a child with 
acute myocarditis due to M. pneumoniae and analyse all documented cases of 
Mycoplasma infection in our hospital over a one year period. 
 
Case report 
Our patient, a 6 year old boy, was admitted to hospital in July 2004 with a 4 day 
history of pyrexia up to 104°F, headache, loose stools and lethargy together with a 
one day history of shortness of breath. He had been started on miocamycin (a newer 
macrolide) by his general practitioner one day prior to admission. He is a known 
asthmatic on prophylactic inhaled steroids. 
On admission he was very pale, sweaty and tachypnoiec with a temperature of 
99.8°F and a regular heart rate of 155bpm. The first and second heart sounds were 
normal and there was a loud third sound. Blood pressure was 78/52mmHg. The 
chest was clear and there was mild hepatomegaly and no rashes. Oxygen saturation 
was 97% in air. His leukocyte count was normal and his C-reactive protein was 
significantly increased (223mg/L). A chest X-Ray showed cardiomegaly and 
pulmonary oedema and an echocardiogram showed decreased fractional shortening 
(25%) and mitral incompetence. There were no effusions and no vegetations. 
A working diagnosis of myocarditis with decompensated shock was made and he 
was started on peripheral dobutamine and transferred to intensive care where he 
was ventilated, intravenous ceftriaxone was added and oral miocamycin continued. 
He developed a persistent maculopapular rash, ceftriaxone was changed to 
meropenem and the rash subsided. Blood, urine and CSF cultures were negative 
and an ELISA test for Mycoplasma Pneumoniae IgM was positive. Coxsackie A, 
Coxsackie B, and echovirus antibodies were negative. 
Over the next few days, the child's condition improved, the shortening fraction 
increased from 25% to 40% over a ten day period and mitral regurgitation 
disappeared. He was extubated after 6 days and dobutamine was stopped after 4 
days. Miocamycin was stopped after fourteen days of treatment when the C-reactive 
protein had returned to normal. He was discharged on enalapril, low dose frusemide 
and regular inhaled budesonide. Six months later, he was off all treatment other than 
inhaled steriods for asthma. 
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Mycoplasma infections in St. Luke's Hospital 
A review of all cases of documented Mycoplasma infections in our hospital in the 
year 2004 showed no other cases of carditis, 29 cases of respiratory infections, 13 
cases investigated for pyrexia of unknown origin and 5 miscellaneous cases. 
 
Discussion 
Mycoplasma carditis is an uncommon entity, especially in the paediatric age group. 
Mycoplasma infection affects mostly children and adolescents but the mean age of 
patients with Mycoplasma carditis in the literature is higher (32 years).4,5 It is thought 
that pneumonia with associated myocarditis is commoner in adults while 
extrapulmonary manifestations, such as arthritis and central nervous system 
complications, are commoner in the paediatric age group.6 
The clinical spectrum of respiratory infections caused by M. pneumoniae ranges from 
a complete absence of symptoms to frank pneumonia.3 Only 7-11% of patients 
develop pneumonia, while 5-20% may develop pleural effusion.7,8 However, in 
patients with mycoplasma carditis, the rate of pneumonia and pleural effusion is 
higher (43% and 19% respectively).5 Alternatively, some of the cases of 
Mycoplasma-carditis manifesting without pneumonia may remain undiagnosed and 
classified as idiopathic carditis.9 
The ECG is a sensitive and inexpensive tool for the initial evaluation of suspected 
cases since the diagnosis of carditis may be unclear due to lack of specific cardiac 
symptoms. For example, tachycardia was found in only 43%, and chest pain in 38% 
of the patients with carditis. In contrast, ECG abnormalities were found in 100% of 
reported ECGs.5 Complete heart block due to Mycoplasma carditis has also been 
reported.10 Echocardiography is naturally useful to quantify cardiac function and 
monitor progress. 
ELISA (enzyme linked immunosorbent assay) based methods are the laboratory 
methods of choice and utilize an enzyme immunoassay for Mycoplasma pneumoniae 
specific IgM. This IgM is found in 80% of Mycoplasma pneumoniae cases within 1 
week of infection. Culture of Mycoplasma species usually requires 1-2 weeks3 and is 
successful in only 40-90% of cases.6 
Successful treatment of Mycoplasma carditis hinges on promptly considering 
Mycoplasma as a potential etiologic agent, obtaining proper diagnostic tests for its 
detection, and providing appropriate antimicrobial coverage. The lack of a cell wall 
renders B-lactam antibiotics useless. Macrolides are the agents of choice as they 
inhibit mycoplasma growth, possibly by blocking dissociation of peptidyl tRNA from 
ribosomes, causing RNA-dependent protein synthesis to arrest. Tetracyclines and 
fluoroquinolones may be considered in older patients. 
Long-term sequelae are not infrequent in Mycoplasma carditis. A significant reduction 
in cardiac sequela has been observed. In the earlier review done by Ponka et al in 
1979, 43% of the patients had cardiac sequelae, whereas Potasman et al in 2003 
described a complication rate of less than 30% and this may have been due to better 
antibiotic coverage.5 
 
Conclusion 
M. pneumoniae is a ubiquitous and protean infection. Respiratory syndromes other 
than pneumonia caused by this organism are reported to be 10-20 times more 
frequent than pneumonia. Since most patients with Mycoplasma carditis present 
solely with respiratory symptoms, an ECG may be a useful screening test in 
suspected cases of mycarditis. Appropriate and timely treatment is essential and 
therefore serological testing for Mycoplasma pneumoniae should be part of the 
routine work-up of myocarditis. 
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